Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen

Hany Onsy Habashy, Desmond G. Powe, Cindy M. Staka, Emad A. Rakha, Graham Ball, Andrew R. Green, Mohammed A. Aleskandarany, Emma C. Paish, R. Douglas Macmillan, Robert I. Nicholson,

Breast Cancer Research and Treatment · 2009 · 239 citations · 38 references

DOIFull text

Open access

Concepts

References

38